Afexa Life Sciences Inc. trades
on the Toronto Stock Exchange
under the symbol FXA

Contact Investors Relations

Ms. Jane Tulloch
Senior Director, Investors Relations
Afexa Life Sciences Inc.
1-780 577-3724

IR@afexa.com


Financial Reports


Our financial reports are provided in PDF format. In order to view them you must have Adobe Reader installed. Adobe Reader can be downloaded here.


On March 5, 2010 Afexa Life Sciences Inc. changed its fiscal year end to March 31, 2010. Prior to the year- end filing deadline of June 29, 2010, Afexa will be reporting its new year end results for the transition period October 1, 2009 to March 31, 2010.

2010
Q1 Jun 30, 2010 Interim Financial Reports
Mar 31, 2010 Annual Audited Financial Statements
Q1 Dec 31, 2009 Interim Financial Reports
2009
Sep 30, 2009 Annual Audited Financial Statements
Q3 Jun 30, 2009 Interim Financial Reports
Q2 Mar 31, 2009 Interim Financial Reports
Q1 Dec 31, 2008 Interim Financial Reports
2008
Sep 30, 2008 Annual Audited Financial Statements
Q3 Jun 30, 2008 Interim Financial Reports
Q2 Mar 31, 2008 Interim Financial Reports
Q1 Dec 31, 2007 Interim Financial Reports
2007
Sep 30, 2007 Annual Audited Financial Statements
Q3 Jun 30, 2007 Interim Financial Reports
Q2 Mar 31, 2007 Interim Financial Reports
Q1 Dec 31, 2006 Interim Financial Reports
2006
Sep 30, 2006 Annual Audited Financial Statements
Q3 Jun 30, 2006 Interim Financial Reports
Q2 Mar 31, 2006 Interim Financial Reports
Q1 Dec 31, 2005 Interim Financial Reports
2005
Sep 30, 2005 Annual Audited Financial Statements
Q3 Jun 30, 2005 Interim Financial Reports
Q2 Mar 31, 2005 Interim Financial Reports
Q1 Dec 31, 2004 Interim Financial Reports
2004
Sep 30, 2004 Annual Audited Financial Statements
Q3 Jun 30, 2004 Interim Financial Reports
Q2 Mar 31, 2004 Interim Financial Reports
Q1 Dec 31, 2003 Interim Financial Reports